← Leaderboards
Randal Scot Tibbetts
University Of Wisconsin Madison
$7,405,053
Attributed
$7,615,919
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,615,919 · 10
By mechanism
R01$3,822,714 · 4
R21$2,093,165 · 5
RF1$1,700,040 · 1
Top collaborators
- Udai B Pandey2 shared
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingMutationProteinsPathway InteractionsGeneticProtein FunctionLinkRegulationBinding ProteinsGene ExpressionNeuronsPhosphorylationAtaxia Telangiectasia Mutated ProteinNerve DegenerationResponseDna DamageInsightCellsAllelesDefectExhibitsMalignant NeoplasmsCyclic Amp-Responsive Dna-Binding ProteinMolecular
Grant awards (25)
Genetic analysis of UBQLN2-associated neurodegeneration in frontotemporal dementia$386,449
R01 · FY2024 · AG · contact PI
A humanized mouse model for UBQLN2-associated ALS-dementia$427,625
R21 · FY2023 · AG · contact PI
Genetic enhancement of CREB signaling in Rett Syndrome$194,375
R21 · FY2021 · NS · contact PI
Genetic analysis of UBQLN2-associated neurodegeneration in frontotemporal dementia$1,700,040
RF1 · FY2020 · AG · contact PI
Genetic enhancement of CREB signaling in Rett Syndrome$232,500
R21 · FY2020 · NS · contact PI
Drosophila models for ubiquilin-associated ALS$223,488
R21 · FY2018 · NS · contact PI
Drosophila models for ubiquilin-associated ALS$198,244
R21 · FY2017 · NS · contact PI
Genome maintenance functions of CREB/ATF transcription factors$277,706
R01 · FY2016 · CA · contact PI
Mechanisms of mitochondrial damage in ataxia-telangiectasia$225,260
R21 · FY2016 · NS · contact PI
Genome maintenance functions of CREB/ATF transcription factors$277,706
R01 · FY2015 · CA · contact PI
Mechanisms of mitochondrial damage in ataxia-telangiectasia$187,010
R21 · FY2015 · NS · contact PI
Genome maintenance functions of CREB/ATF transcription factors$269,374
R01 · FY2014 · CA · contact PI
Genome maintenance functions of CREB/ATF transcription factors$277,706
R01 · FY2013 · CA · contact PI
In vivo Analysis of ATM-Regulated Pathways$236,699
R01 · FY2011 · CA · contact PI
Genetic modifiers of motor neuron degeneration$181,913
R21 · FY2011 · NS · contact PI
In vivo Analysis of ATM-Regulated Pathways$244,020
R01 · FY2010 · CA · contact PI
Genetic modifiers of motor neuron degeneration$222,750
R21 · FY2010 · NS · contact PI
In vivo Analysis of ATM-Regulated Pathways$244,020
R01 · FY2009 · CA · contact PI
In vivo Analysis of ATM-Regulated Pathways$100,000
R01 · FY2009 · CA · contact PI
In vivo Analysis of ATM-Regulated Pathways$244,020
R01 · FY2008 · CA · contact PI
Mechanisms of ATR Targeting and Regulation$244,833
R01 · FY2007 · GM · contact PI
Mechanisms of ATR Targeting and Regulation$252,250
R01 · FY2006 · GM · contact PI
Mechanisms of ATR Targeting and Regulation$258,425
R01 · FY2005 · GM
Mechanisms of ATR Targeting and Regulation$258,526
R01 · FY2004 · GM
Mechanisms of ATR Targeting and Regulation$250,980
R01 · FY2003 · GM